InvestorsHub Logo
Followers 113
Posts 11897
Boards Moderated 0
Alias Born 07/10/2014

Re: Sam81 post# 196515

Thursday, 06/13/2019 6:25:40 AM

Thursday, June 13, 2019 6:25:40 AM

Post# of 427375
Samy, JT said yesterday as of yesterday he didn't receive any second letter from FDA. As you know he gave the best presentation yesterday. He said V is the best beating any other drug in the market efficacy wise and cost wise including statins even though he kept saying V is not a competition drug but going to be volume play. He said everything that one can say the best.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News